• Represents major hepatic complication after stem cell transplant
• Common presenting signs are jaundice and hepatomegaly
• Elevated serum alkaline phosphatase and bilirubin
• Variably elevated transaminases
Microscopic
• Bile duct epithelial cell damage is key distinguishing feature
Epithelial cell vacuolization and attenuation
Withering, sloughing, and necrosis of biliary epithelial cells
Lymphocytic infiltration
Ductopenia with progression to chronic disease
• Portal inflammation is typically mild
• Endotheliitis in some cases
• Other nonspecific changes include cholestasis, lobular inflammation and hepatocyte swelling
• Acute hepatitis pattern also described
• Chronic graft-vs.-host disease features ductopenia, fibrosis
• Histologic findings may be focal
Bile Duct Injury in GVHD Mild portal inflammation and bile duct damage are seen in this case of hepatic graft-vs.-host disease (GVHD). The biliary epithelial cells are irregular and unevenly spaced and show cytoplasmic vacuolization . The duct lumen is irregular as well. These are all features of biliary epithelial damage.
Bile Duct Epithelial Cell Injury Bile duct epithelial cell nuclei are pleomorphic, varying in size and polarity, and unevenly spaced in this case of GVHD. There is cytoplasmic vacuolization. The portal inflammation is mild.
Injured Bile Duct This case of GVHD shows mild portal inflammation and biliary epithelial cell injury . The brown pigment indicates iron overload, which is often seen in stem cell transplant recipients. The portal inflammation is mild.
Mild Cholestasis H&E-stained slide shows nonspecific lobular changes seen in GVHD, including cholestasis , mild inflammation, and hepatocyte swelling.
TERMINOLOGY
Abbreviations
• Graft-vs.-host disease (GVHD)
Synonyms
• “Vanishing bile duct syndrome” has been used as synonym, but is not specific term
Refers to loss of bile ducts in chronic GVHD, drug-related cholangitis, or allograft rejection
Definitions
• Attack of immunocompetent, donor-derived cells against recipient tissues
Usually occurs in bone marrow transplant or hematopoietic stem cell transplant recipients
Only gold members can continue reading. Log In or Register to continue